Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | PO / MO |
The patient did not notice and took all four Vivotif capsules instead of one capsule every other day; The patient did not notice and took all four Vivotif capsules instead of one capsule every other day; Case reference number US-BN-2024-002905 is a spontaneous case initially received from a consumer via Med Communications (reference number: USBAV24-3328) on 18-Dec-2024 and concerns a female patient of unknown age. The patient's medical history and concomitant medication details were not provided. On unspecified date, the patient got Vivotif and was aware it should be taken every other day, however, did not notice it was just one capsule and took all four doses of Vivotif (batch number: unknown), at a dose of four capsules, orally, for an unknown indication (explicitly coded as 'inappropriate schedule of vaccine administered' and 'vaccine overdose'). At the time of initial report, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. No further information was provided.; Reporter's Comments: A female patient of unknown age got Vivotif and was aware it should be taken every other day, however, did not notice it was just one capsule and took all four doses of Vivotif for an unknown indication, which is considered as inappropriate schedule of vaccine administered and vaccine overdose. It was unknown if the patient experienced any adverse event due to Vivotif vaccine. Inappropriate schedule of product administration and overdose are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration and overdose are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unknown age got Vivotif and was aware it should be taken every other day, however, did not notice it was just one capsule and took all four doses of Vivotif for an unknown indication, which is considered as inappropriate schedule of vaccine administered and vaccine overdose. It was unknown if the patient experienced any adverse event due to Vivotif vaccine. Inappropriate schedule of product administration and overdose are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration and overdose are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None